is mounjaro glp 1 agonist (tirzepatide) a dual incretin targeting both GLP-1 and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying — which also leads to Holding GLP-1 Agonists Prior to
Description
The only difference is that Bydureon is long-lasting, requiring only one injection per week, whereas Byetta is taken twice-daily due to its much shorter-term effects
The safety profile of GLP-1 injections is well-established, with many individuals experiencing minimal side effects
2024;doi:10.1038/s41591-024-03015-5
J.NewsomeP
The medication works by inhibiting the production of the hormone that is partially responsible for hair loss, dihydrotestosterone (DHT)
